Peptide Therapeutics Drugs Market Report 2024 (Global Edition)

Global Peptide Therapeutics Drugs Market Report 2024 Market Size Split

Peptide Therapeutics Drugs Market Report Description

We have various report editions of Peptide Therapeutics Drugs Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Peptide Therapeutics Drugs Market Insights Video

Competitive Landscape of the Peptide Therapeutics Drugs Market

In the peptide therapeutics drugs market's competitive landscape, numerous key competitors are driving innovation and growth. Key players in the peptide therapeutics drugs market adopt strategies such as extensive R&D investments, strategic partnerships, and mergers to enhance pipeline development. They focus on advanced drug delivery systems, personalized medicine approaches, and global market expansion.

June 2023: Asep Medical received a US$ 200,000 grant from the NanoMedicines Innovation Network to develop a nanoparticle-formulated peptide solution for treating chronic sinus infections caused by biofilms. The grant, funded by Canada's Networks of Centres of Excellence, will aid pre-clinical studies and clinical trials. (Source: https://www.scienceboard.net/index.aspx?sec=ser&sub=def&pag=dis&ItemID=5526)

Top Companies Market Share in Peptide Therapeutics Drugs Industry: (In no particular order of Rank)

• Eli Lilly and Company
• Pfizer Inc.
• Amgen Inc.
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Teva Pharmaceutical Industries Ltd.
• Sanofi
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Novo Nordisk A/S
• GlaxoSmithKline plc.
• Ironwood Pharmaceuticals
• Inc.
• Radius Health
• Inc.
• Ipsen Pharma
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Peptide Therapeutics Drugs Market

Which Region Dominates the Peptide Therapeutics Drugs Market in 2024?

According to Cognitive Market Research, North America currently dominates the peptide therapeutics drugs market, and the region is expected to have significant growth during the projected period. This is due to the region's rising prevalence of chronic diseases, advancements in peptide synthesis and delivery technologies, and a favorable regulatory environment. Increased investment in R&D, the need for personalized medicine, and the emergence of biosimilars further enhance market growth, supported by collaborations between pharmaceutical companies and research institutions.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). This is due to the increasing prevalence of chronic diseases, advancements in peptide synthesis, and a growing biopharmaceutical sector. Favorable regulatory environments, rising investments in R&D, and expanding healthcare infrastructure further support market growth.

The current report Scope analyzes Peptide Therapeutics Drugs Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Peptide Therapeutics Drugs Market

According to Cognitive Market Research, the global peptide therapeutics drugs market size was estimated at USD 38541.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 15416.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the peptide therapeutics drugs market with a market size of USD 12163.60 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. The US market's increasing healthcare expenditure.
• The Canada peptide therapeutics drugs market had a market share of USD 1849.98 million in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period. Canada’s development of various drugs.
• The Mexico peptide therapeutics drugs market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 1402.90 million in 2024.

Europe Peptide Therapeutics Drugs Market

According to Cognitive Market Research, the global peptide therapeutics drugs market size was estimated at USD 38541.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 11562.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• The United Kingdom peptide therapeutics drugs market had a market share of USD 1942.48 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. In the UK, peptide therapeutics drug sales witness an upswing due to the growing awareness among healthcare professionals.
• The France peptide therapeutics drugs market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 1063.74 million in 2024.
• According to Cognitive Market Research, the German peptide therapeutics drugs market size was valued at USD 2289.35 million in 2024 and is projected to grow at a CAGR of 10.2% during the forecast period. In Germany, peptide therapeutics drugs surged due to the increased focus on the major market players.
• The Italy peptide therapeutics drugs market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 994.36 million in 2024.
• The Russia peptide therapeutics drugs market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 1792.17 million in 2024.
• The Spain peptide therapeutics drugs market is projected to witness growth at a CAGR of 9.1% during the forecast period with a market size of USD 948.11 million in 2024
• The Luxembourg peptide therapeutics drugs market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 358.43 million in 2024.
• The Portugal peptide therapeutics drugs market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 242.81 million in 2024.
• The Greece peptide therapeutics drugs market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 138.75 million in 2024.
• The Rest of Europe's peptide therapeutics drugs market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 1792.17 million in 2024.

Asia Pacific Peptide Therapeutics Drugs Market

According to Cognitive Market Research, the global peptide therapeutics drugs market size was estimated at USD 38541.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 8864.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.

• According to Cognitive Market Research, the China peptide therapeutics drugs market size was valued at USD 3989.01 million in 2024 and is projected to grow at a CAGR of 13.0% during the forecast period. Peptide therapeutics drugs surged in China due to the increased focus of the major market players.
• The Japan peptide therapeutics drugs market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 1223.30 million in 2024.
• The India peptide therapeutics drugs market had a market share of USD 1063.74 million in 2024 and is projected to grow at a CAGR of 15.3% during the forecast period. India's advancements in peptide synthesis.
• The South Korean peptide therapeutics drugs market is projected to witness growth at a CAGR of 12.6% during the forecast period, with a market size of USD 886.45 million in 2024.
• The Australian peptide therapeutics drugs market is projected to witness growth at a CAGR of 13.2% during the forecast period, with a market size of USD 460.95 million in 2024.
• The South East Asia peptide therapeutics drugs market is projected to witness growth at a CAGR of 14.5% during the forecast period, with a market size of USD 611.65 million in 2024.
• The Rest of Asia Pacific peptide therapeutics drugs market is projected to witness growth at a CAGR of 13.3% during the forecast period, with a market size of USD 629.38 million in 2024.

South America Peptide Therapeutics Drugs Market

According to Cognitive Market Research, the global peptide therapeutics drugs market size was estimated at USD 38541.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 1927.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil peptide therapeutics drugs market size was valued at USD 824.78 million in 2024 and is projected to grow at a CAGR of 11.50% during the forecast period. Peptide therapeutics drugs flourished in Brazil due to an increased R&D investment by large pharmaceutical companies.
• Argentina's peptide therapeutics drugs market had a market share of USD 323.75 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. Argentina's growing trend in the pharmaceutical industry.
• Colombia peptide therapeutics drugs market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 171.51 million in 2024.
• Peru peptide therapeutics drugs market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 158.02 million in 2024.
• Chile peptide therapeutics drugs market is projected to witness growth at a CAGR of 11.2% during the forecast period, with a market size of USD 138.75 million in 2024.
• The Rest of Latin America's peptide therapeutics drugs market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 310.26 million in 2024.

Middle East and Africa Peptide Therapeutics Drugs Market

According to Cognitive Market Research, the global peptide therapeutics drugs market size was estimated at USD 38541.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 770.82 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2031.

• The GCC Countries' peptide therapeutics drugs market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 329.91 million in 2024. Peptide therapeutics drugs flourish due to the presence of major market players.
• The Egypt peptide therapeutics drugs market is projected to witness growth at a CAGR of 11.50% during the forecast period, with a market size of USD 80.94 million in 2024.
• The South Africa peptide therapeutics drugs market is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 121.79 million in 2024. Peptide therapeutics drug sales flourished in South Africa due to the rising demand for minimally invasive treatments.
• The Turkey peptide therapeutics drugs market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 66.29 million in 2024.
• The Nigeria peptide therapeutics drugs market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 80.94 million in 2024.
• The Rest of the MEA peptide therapeutics drugs market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 90.96 million in 2024.

Peptide Therapeutics Drugs Market Analysis

Segment Analysis of Peptide Therapeutics Drugs Market

Based on present and future trends, the market size is estimated from 2019 to 2031. Moreover, study also provides quantitative and qualitative analysis of each type to understand the driving factors for the fastest growing type segment for Peptide Therapeutics Drugs market.

of Peptide Therapeutics Drugs analyzed in this report are as follows:

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Peptide Therapeutics Drugs Industry. Request a Free Sample PDF!

Segment Analysis of Peptide Therapeutics Drugs Market

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Peptide Therapeutics Drugs from 2019 to 2031. This will also help to analyze the demand for Peptide Therapeutics Drugs across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.

Some of the key of Peptide Therapeutics Drugs are:

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion